Education
About Us
Working with TipRanks
Follow Us
ClouDr Group Limited (HK:9955)
:9955
9955 Stock Chart & Stats
HK$1.00
HK$0.03(2.52%)
At close: 4:00 PM EST
HK$1.00
HK$0.03(2.52%)
Day’s Range― - ―
52-Week RangeHK$0.83 - HK$1.80
Previous CloseN/A
Volume146.50K
Average Volume (3M)1.09M
Market Cap
HK$559.79M
Enterprise ValueHK$668.04M
Total Cash (Recent Filing)HK$445.29M
Total Debt (Recent Filing)HK$558.23M
Price to Earnings (P/E)―
Beta2.12
Next Earnings
Mar 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.01
Shares Outstanding645,718,800
10 Day Avg. Volume899,970
30 Day Avg. Volume1,090,236
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)0.45
Price to Sales (P/S)0.19
P/FCF Ratio-2.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Defensive Retail Pharmacy ModelA retail pharmacy business centered on prescriptions and OTC products benefits from recurring, non-discretionary demand and an essential-healthcare positioning. This provides durable revenue stability and resilience across economic cycles, supporting steady cash flow potential over months.
Stable Gross Profit MarginStable gross margins suggest the company maintains pricing or procurement discipline in core product lines. Sustained margin control at the gross level supports long-term improvement in operating profitability if revenue growth resumes, making margins a durable strength.
Improving Leverage MetricsImproving debt-to-equity and equity ratios indicate stronger balance-sheet management and reduced financial risk. Enhanced leverage metrics increase financial flexibility for capex or store expansion and lower refinancing pressure over the medium term.
Bears Say
Persistent Net LossesOngoing and growing net losses erode retained earnings and limit reinvestment capacity. Persistent unprofitability forces dependence on external funding, constrains strategic initiatives, and raises execution risk on any multi-quarter recovery plan.
Negative Free Cash Flow And Financing RelianceConsistent negative free cash flow and dependence on financing undermine liquidity resilience. Over time this increases exposure to credit cost swings and capital-raising execution risk, potentially forcing cutbacks in investment or store operations if financing tightens.
Historical Negative Equity And High LiabilitiesA history of negative equity and elevated liabilities signals prior capital erosion and creditor concentration. This structural weakness can limit access to capital markets, raise borrowing costs, and hamper strategic expansion until equity is rebuilt sustainably.
ClouDr Group Limited News
9955 FAQ
What was ClouDr Group Limited’s price range in the past 12 months?
ClouDr Group Limited lowest stock price was HK$0.83 and its highest was HK$1.80 in the past 12 months.
What is ClouDr Group Limited’s market cap?
ClouDr Group Limited’s market cap is HK$559.79M.
When is ClouDr Group Limited’s upcoming earnings report date?
ClouDr Group Limited’s upcoming earnings report date is Mar 19, 2026 which is in 25 days.
How were ClouDr Group Limited’s earnings last quarter?
ClouDr Group Limited released its earnings results on Aug 27, 2025. The company reported -HK$1.014 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$1.014.
Is ClouDr Group Limited overvalued?
According to Wall Street analysts ClouDr Group Limited’s price is currently Overvalued.
Does ClouDr Group Limited pay dividends?
ClouDr Group Limited does not currently pay dividends.
What is ClouDr Group Limited’s EPS estimate?
ClouDr Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ClouDr Group Limited have?
ClouDr Group Limited has 645,718,800 shares outstanding.
What happened to ClouDr Group Limited’s price movement after its last earnings report?
ClouDr Group Limited reported an EPS of -HK$1.014 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.907%.
Which hedge fund is a major shareholder of ClouDr Group Limited?
Currently, no hedge funds are holding shares in HK:9955
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ClouDr Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-10.34%
12-Months-Change
Fundamentals
Return on Equity
-69.05%
Trailing 12-Months
Asset Growth
-28.15%
Trailing 12-Months
Company Description
ClouDr Group Limited
ClouDr Group Limited, an investment holding company, provides supplies and software as a service (SaaS) to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for chronic condition management. It distributes hospital supplies, which include medical devices, such as blood glucose meters and vital sign monitors, glucose testing strips, and OTC and prescription drugs; and hospital and pharmacy SaaS and digital marketing services to pharmaceutical companies. The company also provides real time consultation, digital condition tracking, and online prescription and ordering services. ClouDr Group Limited was founded in 2014 and is headquartered in Hangzhou, China.
Technical Analysis
IVD Medical Holding Limited
―
Medlive Technology Co., Ltd.
―
Charmacy Pharmaceutical Co., Ltd. Class H
―
Options Prices
Currently, No data available
---